Insider Selling: Plexus (NASDAQ:PLXS) CFO Sells $732,070.83 in Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) CFO Patrick John Jermain sold 3,587 shares of Plexus stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $204.09, for a total value of $732,070.83. Following the completion of the sale, the chief financial officer directly owned 16,882 shares in the company, valued at approximately $3,445,447.38. The trade was a 17.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Patrick John Jermain also recently made the following trade(s):

  • On Tuesday, February 3rd, Patrick John Jermain sold 4,841 shares of Plexus stock. The shares were sold at an average price of $204.01, for a total value of $987,612.41.
  • On Tuesday, November 11th, Patrick John Jermain sold 2,000 shares of Plexus stock. The shares were sold at an average price of $143.53, for a total transaction of $287,060.00.

Plexus Trading Up 2.6%

Shares of PLXS opened at $206.22 on Monday. The stock has a market capitalization of $5.52 billion, a PE ratio of 32.07 and a beta of 0.81. The company’s fifty day moving average is $165.98 and its 200 day moving average is $148.37. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $208.92.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. During the same quarter last year, the business earned $1.73 earnings per share. Plexus’s quarterly revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Sell-side analysts expect that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Institutional Trading of Plexus

A number of large investors have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Plexus by 7.5% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,955 shares of the technology company’s stock valued at $941,000 after buying an additional 484 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Plexus by 23.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 240,192 shares of the technology company’s stock valued at $34,753,000 after acquiring an additional 45,425 shares in the last quarter. Wedge Capital Management L L P NC increased its holdings in shares of Plexus by 36.6% in the 3rd quarter. Wedge Capital Management L L P NC now owns 27,600 shares of the technology company’s stock valued at $3,993,000 after acquiring an additional 7,393 shares during the period. Nicola Wealth Management LTD. bought a new position in shares of Plexus in the 3rd quarter worth $6,655,000. Finally, Capital Fund Management S.A. lifted its stake in shares of Plexus by 28.4% during the 2nd quarter. Capital Fund Management S.A. now owns 41,043 shares of the technology company’s stock worth $5,554,000 after purchasing an additional 9,076 shares during the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on PLXS shares. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Benchmark increased their price target on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Stifel Nicolaus lifted their price objective on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research note on Friday, January 30th. Needham & Company LLC boosted their price objective on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Finally, Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $189.20.

Read Our Latest Report on PLXS

More Plexus News

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Analysts raised price targets and reiterated constructive coverage (Benchmark, Needham, Williams Trading among others), which supports upside momentum and investor confidence. Read More.
  • Positive Sentiment: Major institutional holders increased positions (e.g., MFS, Wedge Capital), indicating continued institutional demand beneath the surface. Read More.
  • Positive Sentiment: Recent media/analyst pieces highlight Plexus as a top momentum and growth stock for the long term, reinforcing a bullish narrative for growth investors. Read More.
  • Neutral Sentiment: Q4 results showed a very slight EPS beat ($1.78 vs. $1.77 est.) and revenue roughly in line; management set Q2 FY2026 guidance of $1.80–$1.95 EPS — solid but not a clear accelerating catalyst. Read More.
  • Negative Sentiment: Cluster of insider sales by senior executives: CFO Patrick J. Jermain sold shares on Feb 4 (3,587 shares reported), CAO Angelo Ninivaggi Jr. sold 4,303 shares on Feb 5, and Chairman Dean Foate sold 5,000 shares on Feb 2 — combined sales may prompt profit‑taking or signal executives monetizing near recent highs. Read More. Read More. Read More.
  • Negative Sentiment: Other executive sales (including prior CEO sales reported early Feb) add to the appearance of management realizing gains after a sharp run-up, which can weigh on sentiment if sustained. Read More.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Further Reading

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.